# Immunic to Participate in Investor Conferences in November

- Source: PR Newswire M&A
- Published: 2026-11-02T11:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/immunic-to-participate-in-investor-conferences-in-november-302925627.html
- Canonical: https://groundlevelnews.com/story/immunic-to-participate-in-investor-conferences-in-november-a4c253/

NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in November: November 9-11: Guggenheim...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._